1. Low pre-treatment end-tidal CO 2 predicts dropout from cognitive-behavioral therapy for anxiety and related disorders.
- Author
-
Tolin DF, Billingsley AL, Hallion LS, and Diefenbach GJ
- Subjects
- Adult, Anxiety Disorders complications, Anxiety Disorders physiopathology, Anxiety Disorders therapy, Breath Tests, Female, Humans, Hyperventilation metabolism, Hypocapnia complications, Male, Obsessive-Compulsive Disorder complications, Obsessive-Compulsive Disorder physiopathology, Obsessive-Compulsive Disorder therapy, Respiratory Rate physiology, Stress Disorders, Post-Traumatic complications, Stress Disorders, Post-Traumatic physiopathology, Stress Disorders, Post-Traumatic therapy, Stress, Psychological complications, Stress, Psychological physiopathology, Stress, Psychological psychology, Treatment Outcome, Young Adult, Anxiety Disorders metabolism, Carbon Dioxide metabolism, Cognitive Behavioral Therapy, Hyperventilation psychology, Hypocapnia psychology, Obsessive-Compulsive Disorder metabolism, Patient Dropouts, Stress Disorders, Post-Traumatic metabolism, Stress, Psychological metabolism
- Abstract
Recent clinical trial research suggests that baseline low end-tidal CO
2 (ETCO2 , the biological marker of hyperventilation) may predict poorer response to cognitive-behavioral therapy (CBT) for anxiety-related disorders. The present study examined the predictive value of baseline ETCO2 among patients treated for such disorders in a naturalistic clinical setting. Sixty-nine adults with a primary diagnosis of a DSM-5 anxiety disorder, obsessive-compulsive disorder, or posttraumatic stress disorder completed a 4-min assessment of resting ETCO2 , and respiration rate (the first minute was analyzed). Lower ETCO2 was not associated with a diagnosis of panic disorder, and was associated with lower subjective distress ratings on certain measures. Baseline ETCO2 significantly predicted treatment dropout: those meeting cutoff criteria for hypocapnia were more than twice as likely to drop out of treatment, and ETCO2 significantly predicted dropout beyond other pre-treatment variables. Weekly measurement suggested that the lower-ETCO2 patients who dropped out were not responding well to treatment prior to dropout. The present results, along with previous clinical trial data, suggest that lower pre-treatment ETCO2 is a negative prognostic indicator for CBT for anxiety-related disorders. It is suggested that patients with lower ETCO2 might benefit from additional intervention that targets respiratory abnormality., (Copyright © 2016 Elsevier Ltd. All rights reserved.)- Published
- 2017
- Full Text
- View/download PDF